Research Progress on Epigenetic Regulation in Neurodegenerative Diseases
DOI:
https://doi.org/10.54097/a7jfag88Keywords:
Epigenetic Regulation, DNA Lamentation, Histone Modification, Non-Coding RNA, Neurodegenerative Diseases, Alzheimer’s Disease, Parkinson’s DiseaseAbstract
Neurodegenerative diseases, such as Alzheimer’s disease (AD) and Parkinson’s disease (PD), are characterized by the progressive loss of neurons or deterioration in their structure and function, posing significant burdens on both society and affected families. Increasing evidence suggests that their pathogenesis is closely associated with epigenetic regulatory mechanisms, including DNA methylation, histone modifications, and non-coding RNAs. epigenetic regulation refers to molecular mechanisms that modulate gene expression without altering the DNA sequence, such as dynamic changes in DNA lamentation and gene silencing mediated by non-coding RNAs. These mechanisms influence neuronal differentiation, apoptosis, and functional status, thereby impacting the development and maintenance of the nervous system. An expanding body of research has highlighted the associations between various epigenetic factors and Neurodegenerative diseases, supporting the clinical translation of circulating non-coding RNAs as non-invasive diagnostic biomarkers. These findings provide potential targets for early intervention and the development of novel therapeutic strategies. This review aims to systematically summarize recent advances in the study of epigenetic regulation in human Neurodegenerative diseases. Through a comprehensive analysis of the relevant literature, we elucidate the key mechanistic roles of epigenetic regulation in disease onset and progression, offering a theoretical basis for identifying potential diagnostic markers and therapeutic targets. Ultimately, this review seeks to contribute new insights and strategies for delaying neurodegeneration and improving the prevention and treatment of Neurodegenerative disorders.
Downloads
References
[1] Kang, J. T., Liang, Q. J., Liang, C., & Wang, P. C. Progress in Epigenetics Research. Science & Technology Review, 31, 66–74 (2013).
[2] Goldberg, A. D., Allis, C. D. & Bernstein, E. Epigenetics: a landscape takes shape. Cell 128, 635–638 (2007).
[3] Holliday, R. Epigenetics: a historical overview. Epigenetics 1, 76–80 (2006).
[4] Allis, C. D. & Jenuwein, T. The molecular hallmarks of epigenetic control. Nat. Rev. Genet. 17, 487–500 (2016).
[5] Muller, H. J. & Altenburg, E. The Frequency of Translocations Produced by X-Rays in Drosophila. Genetics 15, 283–311 (1930).
[6] Gene Action in the X-chromosome of the Mouse (Mus musculus L.) | Nature. https://www. nature. com/ articles/ 190372a0.
[7] Surani, M. A. H., Barton, S. C. & Norris, M. L. Development of reconstituted mouse eggs suggests imprinting of the genome during gametogenesis. Nature 308, 548–550 (1984).
[8] Kornberg, R. D. Chromatin structure: a repeating unit of histones and DNA. Science 184, 868–871 (1974).
[9] Mizzen, C. A. et al. The TAF(II)250 subunit of TFIID has histone acetyltransferase activity. Cell 87, 1261–1270 (1996).
[10] Ogryzko, V. V., Schiltz, R. L., Russanova, V., Howard, B. H. & Nakatani, Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87, 953–959 (1996).
[11] Bannister, A. J. & Kouzarides, T. The CBP co-activator is a histone acetyltransferase. Nature 384, 641–643 (1996).
[12] The language of covalent histone modifications | Nature. https://www.nature.com/articles/47412.
[13] Mochizuki, K., Fine, N. A., Fujisawa, T. & Gorovsky, M. A. Analysis of a piwi-Related Gene Implicates Small RNAs in Genome Rearrangement in Tetrahymena. Cell 110, 689–699 (2002).
[14] He, Y.-F. et al. Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science 333, 1303–1307 (2011).
[15] Ito, S. et al. Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature 466, 1129–1133 (2010).
[16] Jones, P. A. & Baylin, S. B. The epigenomics of cancer. Cell 128, 683–692 (2007).
[17] DNMT3A Mutations in Acute Myeloid Leukemia | New England Journal of Medicine. https://www.nejm.org/doi/full/10.1056/NEJMoa1005143.
[18] Dawson, M. A. & Kouzarides, T. Cancer epigenetics: from mechanism to therapy. Cell 150, 12–27 (2012).
[19] Li, X. et al. Global, regional, and national burden of Alzheimer’s disease and other dementias, 1990-2019. Front. Aging Neurosci. 14, 937486 (2022).
[20] Steinmetz, J. D. et al. Global, regional, and national burden of disorders affecting the nervous system, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol. 23, 344–381 (2024).
[21] Nichols, E. et al. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health 7, e105–e125 (2022).
[22] Fischer, A., Sananbenesi, F., Wang, X., Dobbin, M. & Tsai, L.-H. Recovery of learning and memory is associated with chromatin remodelling. Nature 447, 178–182 (2007).
[23] Mattei, A. L., Bailly, N. & Meissner, A. DNA methylation: a historical perspective. Trends Genet. 38, 676–707 (2022).
[24] A family of human zinc finger proteins that bind methylated DNA and repress transcription - PubMed. https://pubmed.ncbi.nlm.nih.gov/16354688/.
[25] Hendrich, B. & Bird, A. Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol. Cell. Biol. 18, 6538–6547 (1998).
[26] Characterization of MeCP2, a vertebrate DNA binding protein with affinity for methylated DNA - PubMed. https://pubmed.ncbi.nlm.nih.gov/1408825/.
[27] Meehan, R. R., Lewis, J. D., McKay, S., Kleiner, E. L. & Bird, A. P. Identification of a mammalian protein that binds specifically to DNA containing methylated CpGs. Cell 58, 499–507 (1989).
[28] Bird, A. DNA methylation patterns and epigenetic memory. Genes Dev. 16, 6–21 (2002).
[29] Okano, M., Bell, D. W., Haber, D. A. & Li, E. DNA Methyltransferases Dnmt3a and Dnmt3b Are Essential for De Novo Methylation and Mammalian Development. Cell 99, 247–257 (1999).
[30] Kriaucionis, S. & Bird, A. DNA methylation and Rett syndrome. Hum. Mol. Genet. 12, R221–R227 (2003).
[31] Reactivation of an Inactive Human X Chromosome: Evidence for X Inactivation by DNA Methylation | Science. https://www.science.org/doi/abs/ 10.1126/science.6164095? ijkey=0908907228 b8cdbf33c24c 04a68b03de18fe0bfc&keytype2=tf_ipsecsha.
[32] Hernandez, D. G. et al. Distinct DNA methylation changes highly correlated with chronological age in the human brain. Hum. Mol. Genet. 20, 1164–1172 (2011).
[33] Wyss-Coray, T. Ageing, neurodegeneration and brain rejuvenation. Nature 539, 180–186 (2016).
[34] Sakabe, K., Wang, Z. & Hart, G. W. β-N-acetylglucosamine (O-GlcNAc) is part of the histone code. Proc. Natl. Acad. Sci. 107, 19915–19920 (2010).
[35] Allfrey, V. G., Faulkner, R. & Mirsky, A. E. ACETYLATION AND METHYLATION OF HISTONES AND THEIR POSSIBLE ROLE IN THE REGULATION OF RNA SYNTHESIS. Proc. Natl. Acad. Sci. 51, 786–794 (1964).
[36] Bannister, A. J. & Kouzarides, T. Regulation of chromatin by histone modifications. Cell Res. 21, 381–395 (2011).
[37] Kabir, F., Atkinson, R., Cook, A. L., Phipps, A. J. & King, A. E. The role of altered protein acetylation in neurodegenerative disease. Front. Aging Neurosci. 14, 1025473 (2023).
[38] Martínez-Cerdeño, V. et al. N-Myc and GCN5 regulate significantly overlapping transcriptional programs in neural stem cells. PLoS ONE 7, e39456 (2012).
[39] Peleg, S. et al. Altered histone acetylation is associated with age-dependent memory impairment in mice. Science 328, 753–756 (2010).
[40] Oki, M., Aihara, H. & Ito, T. Role of histone phosphorylation in chromatin dynamics and its implications in diseases. Subcell. Biochem. 41, 319–336 (2007).
[41] Gurley, L. R., D’Anna, J. A., Barham, S. S., Deaven, L. L. & Tobey, R. A. Histone Phosphorylation and Chromatin Structure during Mitosis in Chinese Hamster Cells. Eur. J. Biochem. 84, 1–15 (1978).
[42] Hirota, T., Lipp, J. J., Toh, B.-H. & Peters, J.-M. Histone H3 serine 10 phosphorylation by Aurora B causes HP1 dissociation from heterochromatin. Nature 438, 1176–1180 (2005).
[43] Goto, H., Yasui, Y., Nigg, E. A. & Inagaki, M. Aurora-B phosphorylates Histone H3 at serine28 with regard to the mitotic chromosome condensation. Genes Cells 7, 11–17 (2002).
[44] Sugiyama, K. et al. Aurora-B associated protein phosphatases as negative regulators of kinase activation. Oncogene 21, 3103–3111 (2002).
[45] Xin, G. et al. Aurora B regulates PP1γ–Repo-Man interactions to maintain the chromosome condensation state. J. Biol. Chem. 295, 14780–14788 (2020).
[46] He, L. & Hannon, G. J. Micrornas: Small RNAs with a big role in gene regulation. Nat. Rev. Genet. 5, 522–531 (2004).
[47] Ambros, V. The functions of animal microRNAs. Nature 431, 350–355 (2004).
[48] Gui, Y., Liu, H., Zhang, L., Lv, W. & Hu, X. Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease. Oncotarget 6, 37043–37053 (2015).
[49] Zhao, Y., Pogue, A. & Lukiw, W. MicroRNA (miRNA) Signaling in the Human CNS in Sporadic Alzheimer’s Disease (AD)-Novel and Unique Pathological Features. Int. J. Mol. Sci. 16, 30105–30116 (2015).
[50] Kirchner, S. & Ignatova, Z. Emerging roles of tRNA in adaptive translation, signalling dynamics and disease. Nat. Rev. Genet. 16, 98–112 (2015).
[51] Deciphering the tRNA-derived small RNAs: origin, development, and future | Cell Death & Disease. https://www.nature.com/articles/s41419-021-04472-3.
[52] Tan, D. M., Tan, Y., & Duan, E. K. Advances and Prospects of tsRNA Research. Progress in Biochemistry and Biophysics, 46, 1063–1072 (2019).
[53] Tao, E., Cheng, W. Y., Li, W., Yu, J. & Gao, Q. tiRNAs: A novel class of small noncoding RNAs that helps cells respond to stressors and plays roles in cancer progression. J. Cell. Physiol. 235, 683–690 (2020).
[54] Using tRNA halves as novel biomarkers for the diagnosis of gastric cancer - PubMed. https:// pubmed. ncbi.nlm.nih.gov/31104009/.
[55] Kuscu, C. et al. tRNA fragments (tRFs) guide Ago to regulate gene expression post-transcriptionally in a Dicer-independent manner. RNA 24, 1093–1105 (2018).
[56] Goodarzi, H. et al. Endogenous tRNA-Derived Fragments Suppress Breast Cancer Progression via YBX1 Displacement. Cell 161, 790–802 (2015).
[57] Guzzi, N. et al. Pseudouridylation of tRNA-Derived Fragments Steers Translational Control in Stem Cells. Cell 173, 1204-1216.e26 (2018).
[58] Zhang, S. et al. Identification of functional tRNA-derived fragments in senescence-accelerated mouse prone 8 brain. Aging 11, 10485–10498 (2019).
[59] tRNA-Derived Fragments in Alzheimer’s Disease: Implications for New Disease Biomarkers and Neuropathological Mechanisms - PubMed. https://pubmed.ncbi.nlm.nih.gov/33337366/.
[60] Magee, R., Londin, E. & Rigoutsos, I. TRNA-derived fragments as sex-dependent circulating candidate biomarkers for Parkinson’s disease. Parkinsonism Relat. Disord. 65, 203–209 (2019).
[61] Identification of functional tRNA-derived fragments in senescence-accelerated mouse prone 8 brain - PubMed. https://pubmed.ncbi.nlm.nih.gov/31746776/.
[62] Xue, X. Y., Guo, X. H., Li, M., & Luo, H. M. Research Progress on the Pathogenesis of Neurodegenerative Diseases. Chinese Journal of Gerontology, 35, 3149–3152 (2015).
[63] Dementia fact sheet | Alzheimer’s Disease International (ADI). https://www.alzint.org/ resource/ dementia-fact-sheet/.
[64] Soria Lopez, J. A., González, H. M. & Léger, G. C. Chapter 13 - Alzheimer’s disease. in Handbook of Clinical Neurology (eds. Dekosky, S. T. & Asthana, S.) vol. 167 231–255 (Elsevier, 2019).
[65] Zhang, J. S. & Wang, R. Research Progress on the Pathogenesis of Alzheimer’s Disease. Journal of Capital Medical University, 35, 721–724 (2014).
[66] Singer, O. et al. Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model. Nat. Neurosci. 8, 1343–1349 (2005).
[67] Scheltens, P. et al. Alzheimer’s disease. The Lancet 397, 1577–1590 (2021).
[68] Veerappan, C. S., Sleiman, S. & Coppola, G. Epigenetics of Alzheimer’s Disease and Frontotemporal Dementia. Neurotherapeutics 10, 709–721 (2013).
[69] Bollati, V. et al. DNA methylation in repetitive elements and Alzheimer disease. Brain. Behav. Immun. 25, 1078–1083 (2011).
[70] Waseem Bihaqi, S. & H. Zawia, N. Alzheimer’s disease biomarkers and epigenetic intermediates following exposure to Pb in vitro. Curr. Alzheimer Res. 9, 555–562 (2012).
[71] Tan, L., Yu, J.-T., Hu, N. & Tan, L. Non-coding RNAs in Alzheimer’s Disease. Mol. Neurobiol. 47, 382–393 (2013).
[72] Masliah, E., Dumaop, W., Galasko, D. & Desplats, P. Distinctive patterns of DNA methylation associated with Parkinson disease. Epigenetics 8, 1030–1038 (2013).
[73] Thomson Reuters. Disease Review: Parkinson’s Disease. International Journal of Pharmaceutical Research, 42, 338–345 (2015).
[74] Desplats, P. et al. α-Synuclein Sequesters Dnmt1 from the Nucleus. J. Biol. Chem. 286, 9031–9037 (2011).
[75] α-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity | Human Molecular Genetics | Oxford Academic. https://academic.oup. com/hmg/article/15/20/ 3012/2355955? login=true.
[76] Magee, R., Londin, E. & Rigoutsos, I. TRNA-derived fragments as sex-dependent circulating candidate biomarkers for Parkinson’s disease. Parkinsonism Relat. Disord. 65, 203–209 (2019).
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

